Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults
Clinical trial NCT03208322 · WITHDRAWN
Trial details
- NCT number
- NCT03208322
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-30
- Primary completion
- 2019-02-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.